1-[4-[methyl-[[5-(2-methylpyrazol-3-yl)-2-thienyl]sulfonyl]amino]phenyl]-3-phenyl-urea

ID: ALA4649149

Chembl Id: CHEMBL4649149

PubChem CID: 49841250

Max Phase: Preclinical

Molecular Formula: C22H21N5O3S2

Molecular Weight: 467.58

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(c1ccc(NC(=O)Nc2ccccc2)cc1)S(=O)(=O)c1ccc(-c2ccnn2C)s1

Standard InChI:  InChI=1S/C22H21N5O3S2/c1-26-19(14-15-23-26)20-12-13-21(31-20)32(29,30)27(2)18-10-8-17(9-11-18)25-22(28)24-16-6-4-3-5-7-16/h3-15H,1-2H3,(H2,24,25,28)

Standard InChI Key:  URQXSAGNGHPINO-UHFFFAOYSA-N

Associated Targets(Human)

ITGB1 Tclin Integrin alpha2/beta1 (69 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 467.58Molecular Weight (Monoisotopic): 467.1086AlogP: 4.62#Rotatable Bonds: 6
Polar Surface Area: 96.33Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.73CX Basic pKa: 1.70CX LogP: 3.77CX LogD: 3.77
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.43Np Likeness Score: -1.96

References

1. Zheng Y, Leftheris K..  (2020)  Insights into Protein-Ligand Interactions in Integrin Complexes: Advances in Structure Determinations.,  63  (11): [PMID:31999923] [10.1021/acs.jmedchem.9b01869]

Source